Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Ustekinumab 45 Mg/0.5 Ml Subcut Soln 0.5 Ml [Webs] (CDM 9160030) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 25, 2026 , from http://ppman.hank.ai/transparency/procedure/9160030/by-state?code_type=CDM
“Ustekinumab 45 Mg/0.5 Ml Subcut Soln 0.5 Ml [Webs] (CDM 9160030) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/9160030/by-state?code_type=CDM. Accessed
October 25, 2026 .
“Ustekinumab 45 Mg/0.5 Ml Subcut Soln 0.5 Ml [Webs] (CDM 9160030) by State,” HANK Price Transparency ,
accessed October 25, 2026 ,
http://ppman.hank.ai/transparency/procedure/9160030/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
9160030 — Ustekinumab 45 Mg/0.5 Ml Subcut Soln 0.5 Ml [Webs]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$17,918
National median
$15,031 – $19,212
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 9160030 (CDM), with interquartile range
State Median p25 p75
NE $17,918 $15,031 $19,212